Form 8-K - Current report:
SEC Accession No. 0001493152-24-045199
Filing Date
2024-11-13
Accepted
2024-11-13 17:16:10
Documents
14
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43200
2 ex99-1.htm EX-99.1 22293
  Complete submission text file 0001493152-24-045199.txt   248613

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE shph-20241113.xsd EX-101.SCH 3030
4 XBRL LABEL FILE shph-20241113_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE shph-20241113_pre.xml EX-101.PRE 24175
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 241455669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)